Anavex Life Sciences Corp. (AVXL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.15M | -8.6M | -12.46M | -5.86M | -12.12M | -6.66M | -5.18M | -11.66M | -7.32M | -5.85M | -7.65M | -8.49M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 41% | -29.23% | -140.62% | 49.76% | -65.62% | -13.82% | 32.31% | -37.31% | -26.3% | -44.65% | -8.5% | 11.94% |
| Net Income | -5.68M | -9.83M | -13.24M | -11.2M | -12.11M | -11.62M | -12.21M | -10.55M | -8.62M | -10.15M | -11.28M | -13.11M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.11M | 3.72M | 4.32M | 1.45M | 2.06M | 2.01M | 2.49M | 2.65M | 2.29M | 3.19M | 3.87M | 3.97M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 0 | 0 | 0 | 0 | 59K | -59K | 0 | 0 | 500 | 0 | 845K |
| Working Capital Changes | -2.58M | -2.5M | -3.54M | 3.89M | -2.06M | 2.89M | 4.61M | -3.76M | -982K | 1.11M | -239K | -197K |
| Change in Receivables | -35K | 11K | -154K | 1.89M | -108K | -729K | 2.06M | -236K | -840K | -543.45K | 2.57M | -643K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.61M | -2.49M | 2.01M | 167K | -5.06M | 6.07M | -164K | -566K | -30K | 168.93K | -2.13M | 993K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 36.32M | 10.02M | -2.14M | 852K | 708K | 89K | 4.55M | 7.28M | 59K | 2.06M | 9M | 18.33M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 36.32M | 10.46M | 119K | 852K | 708K | 89K | 4.11M | 7.28M | 59K | 1.19M | 8.53M | 18.15M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -445K | -2.26M | 852K | 708K | 89K | 444K | 7.28M | 59K | 868.34K | 469K | 181.5K |
| Net Change in Cash | 29.17M | 1.41M | -14.61M | -5M | -11.41M | -6.57M | -630K | -4.38M | -7.26M | -3.79M | 1.35M | 9.85M |
| Free Cash Flow | -7.15M | -8.6M | -12.46M | -5.86M | -12.12M | -6.66M | -5.18M | -11.66M | -7.32M | -5.85M | -7.65M | -8.49M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 41% | -29.23% | -140.62% | 49.76% | -65.62% | -13.82% | 32.31% | -37.31% | -26.3% | -44.65% | -8.5% | 11.94% |
| FCF per Share | -0.08 | -0.10 | -0.15 | -0.07 | -0.14 | -0.08 | -0.06 | -0.14 | -0.09 | -0.07 | -0.09 | -0.11 |
| FCF Conversion (FCF/Net Income) | 1.26x | 0.88x | 0.94x | 0.52x | 1.00x | 0.57x | 0.42x | 1.11x | 0.85x | 0.58x | 0.68x | 0.65x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 41K | 16K | 73K | -7K | 43K | 80K | 0 | 173K | 47K | -72.58K | 69K | 90K |